INMED PHARMACEUTICALS INC. Increase (Decrease) in Prepaid Expense and Other Assets
INMED PHARMACEUTICALS INC. (INM) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$83.04 thousand for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$377.86K.
- INMED PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was -$227.84K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | -$377.86K derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | -$83.04K S-4/A · filed 2026-09-09 | ||
| 2026-03-31 | $294.82K S-4 · filed 2026-07-02 | |||
| 2025-06-30 | -$227.84K derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | -$166.26K S-4/A · filed 2026-09-09 | -$173.98K S-4 · filed 2026-07-02 | |
| 2025-03-31 | $61.58K S-4 · filed 2026-07-02 | |||
| 2024-06-30 | -$20.28K S-4 · filed 2026-07-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |